Download
1 / 14
150 likes | 266 Views
This report outlines key data and indicators related to pharmacy core functions aimed at ensuring safe, effective, and efficient medication use. Notably, it addresses a total variance of $6,915,000 in drug costs and highlights substantial increases in inpatient drug expenditures and organ transplant volumes (230% for heart transplants and 81% for Allogenic BMT from FY09 to FY12). The document also details the impact of Rx interventions in reducing prescribing errors and inappropriate orders, emphasizing the importance of continuous medication reconciliation and robust evaluation by pharmacy staff across all transitions of care.
E N D
Pharmacy Core Functions: Safe, Effective, Efficient Medication Use
Total Variance $6,915,000
Inpatient Drug Expenditures and Transplant Volumes Heart Transplant ↑ 230%, Allogenic BMT ↑ 81% from FY09 to FY12
Erythropoetin Expense Reduction Rx intervention to reduce inappropriate orders Price 30% = $225,000 Avoided $530,000 Actual $705,000 Actual $986,000 Actual $751,000 Actual $526,000
Methodology Life Threatening Low Capacity for Harm Serious/Significant
Medication Reconciliation Across Transitions of Care • Changing clinical conditions require continually evaluating the medication lists at each transition
Transition of Care-ISP Service: Nov ‘11 – May ‘12 % of resolved DRPs were classified serious/significant or life-threatening
Medication Use Process and Technology PHYSICIANS/AHPS PHARMACY STAFF MEDICATION ORDER REVIEW UD packager Pharmacist Evaluation, Verification, Monitoring Pharmacy Robot BAR CODE READINESS PROCESS NURSES Liquid UD packager Smart Pump High speed packager TPN Compounder Carousel ADC Med Cart E-MAR Documentation BCMA
Pharmacist Evaluation Process for Medication Orders Label prints in Sterile Compounding Area Order verified if safe and accurate
